Synapse Biomedical

Synapse Biomedical has developed the FDA approved NeuRx Diaphragm Pacing System©, a neurostimulation technology designed to help spinal cord injury and ALS patients decrease their dependency on mechanical ventilation. The technology is also being developed for diaphragm conditioning in respiratory short-term intensive care settings.

Funding: Vivo Ventures, Palo Alto Investors, Case Technology Ventures, JumpStart

Stage: Commercial

News: Synapse Biomedical Receives CE Mark Approval